Housing  Madam Speaker, I appreciate that the Parliamentary Secretary to the Minister of Agriculture and Agri-Food, at the end of his remarks, got to the question of this investment. The issue is that this investment was committed to two years ago. It has been two years since the government finally announced that it was going to get back into the business of building co-ops, and it has not built any.

Housing  Madam Speaker, tonight, I am glad to have a chance to continue pressing for badly needed investments in predictable, ongoing and significant investments for deeply affordable housing with a real focus on co-op housing. It is critical because we are in a housing crisis. One of the reasons for that crisis is that Canada has the lowest percentage of deeply affordable social housing stock in the G7.

Public Complaints and Review Commission Act  Madam Speaker, I really appreciated the words from the member for Calgary Centre in speaking about the need for co-operation in this place. If there was a day when the member was in the party that was governing at that time, could he share with us what productive co-operation would look like in this place from a governing party?

Public Complaints and Review Commission Act  Madam Speaker, I really appreciate the use of the word “co-operation”. We heard it from the member for Calgary Centre—

Business of Supply  Mr. Speaker, the member for Winnipeg South Centre speaks of excesses. One of the realities is we have excess profits in both the oil and gas industry, and among large grocers. I can appreciate there are some words in this motion that might lead it to be one that the member might not be able to support.

Mental Health  Mr. Speaker, an emergency department is not the best place for a person in a mental health crisis, yet more folks are presenting at ERs as a last resort. There are better options and organizations like Thresholds Homes and Supports and the Canadian Mental Health Association of Waterloo Wellington are showing the way.

Petitions  Mr. Speaker, I am honoured to rise to present a petition where petitioners note, first of all, that scientific assessments have already underlined the mix of crises we are facing, including the climate crisis, biodiversity breakdown and resource depletion. The petitioners note that there is no legislation currently in international law with respect to ecocide.

Business of Supply  Madam Chair, I would love to continue that conversation with the minister. As the minister knows, Canada also has one of the highest rates of MS in the world, with more than 90,000 Canadians living with this disease. Of course, while the cause is still unknown, emerging research has highlighted the potential for significant advancements in the prevention of MS.

Business of Supply  Madam Chair, I appreciate the minister for meeting with representatives from MS Canada. It is best that he hear from them directly rather than from me, but it also good to know that there are parliamentarians on all sides who are keen to see the investment made potentially, for example, in the next fall economic statement.

Business of Supply  Madam Chair, can the minister share more about what can be done in working with provinces and territories to address this seeming gap? The issue, it seems, is that Noor cannot access the drug because it is approved by Health Canada but not listed by the Canadian drug agency as recommended for public coverage.

Business of Supply  Madam Chair, absolutely, I would be happy to do that. I appreciate the specificity. I would next like to ask about Dylan and Kim. They are two of many parents in my community who have shared with me what it is like to raise a child living with CF. In their case, it is their son Jackson.

Business of Supply  Madam Chair, as the minister likely knows, because the word “pharmacare” is restricted to contraceptives and diabetes, I hesitate to use it at this point. I know that is the minister's vision for where he wants it to go. However, I am thinking about parents, such as Dylan and Kim, who want to understand more about when this could be expanded to them.

Business of Supply  Madam Chair, would the minister or a member of his team be open to accept a meeting with ACCKWA to hear directly from it about how important the support is for these test kits?

Business of Supply  Madam Chair, I need to move to the next question. My next question is on a concerning limitation in Bill C-64 brought to me by a senior in my community. The bill, of course, is designed to provide coverage for specific prescription drugs and products intended for contraception and the treatment of diabetes.

Business of Supply  Madam Chair, I am encouraged to hear that on both fronts. I appreciate that. I would like to tell the minister about another constituent of mine, Noor Ayesha. Noor is battling an incurable rare cancer. For it, she requires an oral drug. The name is Pemazyre. It has been approved by Health Canada but is not recommended by the Canadian drug agency for public coverage.